论文部分内容阅读
目的探究对缺血性脑血管病颈部动脉斑块患者采用阿托伐他汀治疗的成效。方法抽取2014年1月~2016年12月来本院就诊的缺血性脑血管病颈部动脉斑块患者200例并分为两组,对照组100例予以阿司匹林加以治疗,试验组100例在对照组加以治疗这一前提下添加阿托伐他汀钙加以治疗,并对比探究两组患者经过治疗前后的斑块面积、颈动脉内中膜厚度(IMT)、各项临床指数状况等。结果比较表明,试验组经过治疗以后的斑块面积、颈动脉内中膜厚度(IMT)、各项临床指数状况都好于对照组,同时P<0.05。结论对缺血性脑血管病颈部动脉斑块患者应用阿托伐他汀加以治疗具备极为显著的成效,值得大力推行及应用。
Objective To investigate the effect of atorvastatin on patients with ischemic cerebrovascular disease with atherosclerotic plaque. Methods A total of 200 patients with ischemic cerebrovascular disease with carotid artery plaque from January 2014 to December 2016 were selected and divided into two groups. One hundred patients in the control group were treated with aspirin. One hundred patients in the test group were treated with aspirin Control group to be treated under the premise of adding atorvastatin calcium to be treated, and compared the two groups to explore the plaque area before and after treatment, carotid intima-media thickness (IMT), the clinical index status. The results showed that the plaque area, carotid intima-media thickness (IMT) and clinical indexes in the experimental group were better than those in the control group after treatment, P <0.05. Conclusions The application of atorvastatin to ischemic cerebrovascular disease patients with atherosclerotic plaque has a very significant effect, which is worth to be vigorously promoted and applied.